Please login to the form below

Not currently logged in
Email:
Password:

Boston Pharma appoints ex-Pfizer and Sanofi executives

Santiago Arroyo and Constantine Chinoporos join its senior team

Constantine ChinoporosBoston Pharmaceuticals has appointed Santiago Arroyo as chief medical officer and Constantine Chinoporos as chief business officer to further build and develop its portfolio.

The company is led by ex-Sanofi CEO Chris Viehbacher and one of Boston's new senior hires comes from the French pharma firm.

Chinoporos was previously vice president of global licensing and business development at Sanofi and has also served as vice president of corporate development at Genzyme and alliance manager or primary care product group at Lilly.

He said: “Boston Pharmaceuticals is intensely focused on efficient clinical development of new medicines and I look forward to helping build an extensive portfolio of new and novel products.

“This is an opportunity to leverage my extensive network of industry partners in identifying great licensing opportunities that can ultimately benefit patients.”

Santiago ArroyoMeanwhile, Arroyo (pictured left) arrives from Pfizer, where he was senior vice president and chief medical officer, having previously also held senior positions at Bristol-Myers Squibb and Eisai.

He said: “I am excited to be part of Boston Pharmaceuticals and to join the team creating a substantial portfolio of clinical programmes across important disease states to bring new medicine to patients.

“I look forward to partnering with biotechnology and biopharmaceutical companies in identifying and further developing potential new medicines.” 

27th November 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics